Company: BIAF
Filing Date: 2025-05-08
Form Type: 8-K
Source: 0001641172-25-009309
Chunk: 1

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-05-08
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item
9.01 Financial Statements and Exhibits.

(d)
Exhibits

  Exhibit      Description                                                                                                                     
  No.                                                                                                                                          
  1.1*         Placement Agency Agreement, dated as of May 5, 2025, by and between bioAffinity Technologies, Inc. and WallachBeth Capital LLC  
 ───────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
  4.1*         Form of Pre-Funded Warrant                                                                                                      
  4.2*         Form of May 2025 Warrant                                                                                                        
  4.3*         Form of Placement Agent Warrant                                                                                                 
  10.1*        Form of Securities Purchase Agreement                                                                                           
  99.1*        Press Release dated May 6, 2025                                                                                                 
  99.2         Press Release dated May 7, 2025                                                                                                 
  104          Cover                                                                                                                           

  Filed     

SIGNATURES

Pursuant
to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this Current Report on Form 8-K
to be signed on its behalf by the undersigned hereunto duly authorized.

  Date:      May          BIOAFFINITY                                          
             8, 2025      TECHNOLOGIES, INC.                                   
 ───────────────────────────────────────────────────────────────────────────────
                          By:                     /s/                          
                          Name:                   Maria                        
                          Title:                  President